Member Info for David1951c

Big factor is cost BRES phases 1 and 2 require $160m funding - FAR requires $520m. BRES are aiming to produce quickly perhaps in 12 months.

By the end of Q1 there should be three JORCs for Camp Load/Northern Syncline (released last year), Iyan due imminently and Beehive by the end of March. The total should be significant and show the magnitude of the deposits. This has the makings of world class potential and must attract a lot of attention.

I understand the number of shares shown on LSE includes warrants (64m) hence the higher number and MCap at 9p.

This can only help BRES to advance discussions on good terms. US must have alternative supply sources in mind and the next important news could be increased DFC funding at scale to get meaningful production more quickly eg. combine phase 1 and 2.

Yes, thanks. There should also be an RNS in Q1 about completion of Oman acquisition. The numbers in April including Oman should be impressive. MCap compared to peers looks very low based on production boepd and low costs.

Lucky,

Also Chile production starts later in 2026 and Sudan should also be progressing.

Helpful responses but this has caused huge alarm and selling. The only question is the level of discount from 2p that SP has been hovering around and will the discount be from new floor? This is another look of a retail investor shafting but I hope not.

Key point is to get more offtake agreements in place as quickly as possible. Bres are in competition with the likes of Sovereign but with the highest quality and a faster route to production possible, Bres should be ahead in the race. With more agreements it might be possible to get phases 2 starting sooner.

Jundee is correct. According to BRES website there are 477m shares plus 64m warrants that show on LSE as total 543m and are used to work out MCap of £42m. There are also 27m options not included. This was last updated on 27 January. Also there are no large shareholders shown above 5%. The company seems mainly owned by PIs.

THX's record Q4 results indicated in previous RNS were based on an achieved gold price of $4,189. So Q1 should be well above that unless the gold price drops further. The market is volatile but THX is still one of the most profitable based on lower quartile AISC.

Added at 7.97 shown as a sell. BRES is a diversification from gold and has huge potential.

Agree. Further funding from DFC would be a huge plus and signal this as a priority for early production.

BRES is also provides deversity away from gold and silver which are volatile as today has shown. The SP drop has largely been recovered and with further early news the SP could move up significantly. Many parties are interested in the graphite and funders are likely to be highly supportive especially as the JORC increases with further drilling. Lots to come.

The big unknown factor is the continuation with NCI and if renewed what the contract value will be. It could be a few million $ pa.

Agree Bod. I am in much the same position buying some well over 1p a few years ago and averaging down since the big drop. Now have almost 1% (in different accounts including in JISAs) and in good paper profit.

One issue I see with Apta is the lack of significant revenue. The legacy of heavily discounted fund raising, which should be over, may deter some past holders. Right now metals are on a tear and I have a few of those in significant profit. That's where the action is right now and money going in rather than on small biotechs. I hope that will change as I really believe that Apta is a rising star but needs to show higher revenues. They have many customers in the top echelons but rvenues per contract are not huge. That could all change if the Unilever programmes move to the next stages - news eagerly awaited.

In investing MCap is a major factor and Apta could well become multiples if the licencing side accelerates. There are numerous others on LSE/ AIM in similar position. I have a chunck of shares in FAB with a low Mcap that should go much higher. GDR and Genincode are in a similar boat - almost on the cusp of breaking out. I tell myself to be patient although with over 100k invested here I sometimes feel I am missing out. Some sellers are looking at missed opportunities.

This unloved sector has been failed by the financial markets with so little support for developing companies and UK plc. Massively discounted fund raising has pulverised PIs who are understandably wary. I expect this will change but it may need a few takeovers for the market to realise the gems they have ignored.

Time for another glass of red.

Have won a contract to build 12 units for homeless people by Tonbridge & Medway Council. Guess this is the low end market but could this sort of development interest ECOB? There seems great potential in this area to place people and not use hotels.

Good spot. Hope Kistos is as bountiful for shareholders as Rockrose was when taken over. Based on 2026 production MCap should be much higher. When Oman completes and 2025 numbers are clearer, there should be a material move up in SP and then more acquisitions to come. Future looks bright indeed.

... also looks undervalued compared to SVML which has a similar MCap to EEE of £240m. Bres seems to be gettting on quietly with their plan for mining and producing graphite to the highest quality 99.99% in a shorter timescale. SVML has strong support from Rio Tinto as a shareholder and possible REEs in the mix.

As things stand BRES is inching ahead in the route to production. More news in Q! should be a catalyst for a SP rise.

This is no surprise and positions FAB to move forward more quickly. Potential customers need to be reassured the company is in good shape financially when due diligence is carried out. A raise at current SP is excellent in current market conditions. The discussions with NCI are crucial and FAB are able to conduct them from a stronger position.

Getting the first contracts and renewing the agreement with NCI in the coming months is now more likely.

Unaudited results were in RNS in October and hopefully finals will not be materially different. It remains to be seen if there is a further trading update unless there are more major contract developments.

looking at previous years' accounts suggests a complex situation and impossible to say what net might be. tax charges will be miti***ed by $28m rebate receivable in december. it must be expected that aa will use the cash to further expand the business and tax will be minimised. further insights will come with the 2025 accounts including the production costs, which seem low in balder and oman.

production guidance seems conservative with further to come from balder v and gas storage ramp up. all looks promising assuming te completed of oman acqusition in q1.